FR 167653, a p38 mitogen-activated protein kinase inhibitor, suppresses the development of endometriosis in a murine model

Journal of Reproductive Immunology

Volumn 72, Issue 1-2, 2006, Pages 85-93

  Yoshino, Osamu ^a   Osuga, Yutaka ^a   Koga, Kaori ^a   Hirota, Yasushi ^a   Hirata, Tetsuya ^a   Ruimeng, Xie ^a   Na, Li ^a   Yano, Tetsu ^a   Tsutsumi, Osamu ^a,b   Taketani, Yuji ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Animal model; Endometriosis; IL 6; MCP 1; P38 MAP kinase; Peritoneal fluid

Indexed keywords

1 [7 (4 FLUOROPHENYL) 1,2,3,4 TETRAHYDRO 8 (4 PYRIDYL)PYRAZOLO[5,1 C][1,2,4]TRIAZIN 2 YL] 2 PHENYLETHANEDIONE; DRUG VEHICLE; ESTRADIOL VALERATE; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE MODEL; DONOR; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; INHIBITION KINETICS; MONOCYTE; MOUSE; MOUSE STRAIN; NONHUMAN; ORGAN WEIGHT; OVARIECTOMY; PERITONEAL FLUID; PERITONITIS; PRIORITY JOURNAL;

ANIMALS; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; ENDOMETRIOSIS; FEMALE; INTERLEUKIN-6; MICE; MICE, INBRED BALB C; ORGAN SIZE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE INHIBITORS; PYRAZOLES; PYRIDINES; UTERINE DISEASES; UTERUS;

EID: 33750838575     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jri.2005.02.004     Document Type: Article

References (19)

1. Dabrosin C., Gyorffy S., Margetts P., Ross C., and Gauldie J. Therapeutic effect of angiostatin gene transfer in a murine model of endometriosis. Am. J. Pathol. 161 (2002) 909-918
2. Harada T., Iwabe T., and Terakawa N. Role of cytokines in endometriosis. Fertil. Steril. 76 (2001) 1-10
3. Hatanaka K., Kawamura M., Murai N., Ogino M., Majima M., Ogino K., and Harada Y. FR167653, a cytokine synthesis inhibitor, exhibits anti-inflammatory effects early in rat carrageenin-induced pleurisy but no effect later. J. Pharmacol. Exp. Ther. 299 (2001) 519-527
4. Hirota Y., Osuga Y., Yoshino O., Koga K., Yano T., Hirata T., Nose E., Ayabe T., Namba A., Tsutsumi O., and Taketani Y. Possible roles of thrombin-induced activation of protease-activated receptor 1 in human luteinized granulosa cells. J. Clin. Endocrinol. Metab. 88 (2003) 3952-3957
5. Kawano T., Ogushi F., Tani K., Endo T., Ohmoto Y., Hayashi Y., and Sone S. Comparison of suppressive effects of a new anti-inflammatory compound, FR167653, on production of PGE2 and inflammatory cytokines, human monocytes, and alveolar macrophages in response to endotoxin. J. Leukoc. Biol. 65 (1999) 80-86
6. Kyama C.M., Debrock S., Mwenda J.M., and D'Hooghe T.M. Potential involvement of the immune system in the development of endometriosis. Reprod. Biol. Endocrinol. 1 (2003) 123
7. Lebovic D.I., Mueller M.D., and Taylor R.N. Immunobiology of endometriosis. Fertil. Steril. 75 (2001) 1-10
8. Maruyama M., Osuga Y., Momoeda M., Yano T., Tsutsumi O., and Taketani Y. Pregnancy rates after laparoscopic treatment Differences related to tubal status and presence of endometriosis. J. Reprod. Med. 45 (2000) 89-93
9. Matsuyama W., Wang L., Farrar W.L., Faure M., and Yoshimura T. Activation of discoidin domain receptor 1 isoform b with collagen up-regulates chemokine production in human macrophages: role of p38 mitogen-activated protein kinase and NF-kappa B. J. Immunol. 172 (2004) 2332-2340
10. Momoeda M., Taketani Y., Terakawa N., Hoshiai H., Tanaka K., Tsutsumi O., Osuga Y., Maruyama M., Harada T., Obata K., and Hayashi K. Is endometriosis really associated with pain?. Gynecol. Obstet. Invest. 54 Suppl. 1 (2002) 18-21
11. Nishikawa M., Myoui A., Tomita T., Takahi K., Nampei A., and Yoshikawa H. Prevention of the onset and progression of collagen-induced arthritis in rats by the potent p38 mitogen-activated protein kinase inhibitor FR167653. Arthritis. Rheum. 48 (2003) 2670-2681
12. Nishikori T., Irie K., Suganuma T., Ozaki M., and Yoshioka T. Anti-inflammatory potency of FR167653, a p38 mitogen-activated protein kinase inhibitor, in mouse models of acute inflammation. Eur. J. Pharmacol. 451 (2002) 327-333
13. Nothnick W.B., Curry T.E., and Vernon M.W. Immunomodulation of rat endometriotic implant growth and protein production. Am. J. Reprod. Immunol. 31 (1994) 151-162
14. Ono K., and Han J. The p38 signal transduction pathway: activation and function. Cell Signal. 12 (2000) 1-13
15. Somigliana E., Vigano P., Rossi G., Carinelli S., Vignali M., and Panina-Bordignon P. Endometrial ability to implant in ectopic sites can be prevented by interleukin-12 in a murine model of endometriosis. Hum. Reprod. 14 (1999) 2944-2950
16. Takahashi S., Keto Y., Fujita T., Uchiyama T., and Yamamoto A. FR167653, a p38 mitogen-activated protein kinase inhibitor, prevents Helicobacter pylori-induced gastritis in Mongolian gerbils. J. Pharmacol. Exp. Ther. 296 (2001) 48-56
17. Yamamoto N., Sakai F., Yamazaki H., Nakahara K., and Okuhara M. Effect of FR167653, a cytokine suppressive agent, on endotoxin-induced disseminated intravascular coagulation. Eur. J. Pharmacol. 314 (1996) 137-142
18. Yoshino O., Osuga Y., Hirota Y., Koga K., Hirata T., Harada M., Morimoto C., Yano T., Nishii O., Tsutsumi O., and Taketani Y. Possible pathophysiological roles of mitogen-activated protein kinases (MAPKs) in endometriosis. Am. J. Reprod. Immunol. 52 (2004) 306-311
19. Yoshino O., Osuga Y., Hirota Y., Koga K., Hirata T., Yano T., Ayabe T., Tsutsumi O., and Taketani Y. Endometrial stromal cells undergoing decidualization down-regulate their properties to produce proinflammatory cytokines in response to interleukin-1beta via reduced p38 mitogen-activated protein kinase phosphorylation. J. Clin. Endocrinol. Metab. 88 (2003) 2236-2241